Premium
Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon‐alpha, doxorubicin and 5‐fluorouracil chemotherapy
Author(s) -
Akçali Zafer,
Akin Ebru,
Özyilkan Özgür
Publication year - 2002
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.10896
Subject(s) - medicine , hepatocellular carcinoma , regimen , chemotherapy , hbsag , gastroenterology , fluorouracil , cirrhosis , doxorubicin , hepatitis b virus , oncology , alpha interferon , population , hepatitis b , cisplatin , interferon , immunology , virus , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom